Cypralis Ltd logo

Cypralis Ltd

Cypralis is focused on the discovery and development of innovative therapeutics for the modulation of peptidyl-prolyl isomerases (known as PPIases), a large family of druggable protein targets known to be involved in many acute and chronic diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.cypralis.com
Disease Focus
STOCK CODENon Listed
Address
Babraham Hall, Room 3011, Babraham Research Campus,CB22 3AT
Cambridge
United Kingdom
Email
Contact Number
+44 1223 496000

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/cypralis-limited” connections=”true” suffix=””]